Pentasa

Medicinal product

(Invented) name

Pentasa

Active substance (s)

Mesalazinas

Strength

2 g

Pharmaceutical form

pailginto atpalaidavimo granulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07EC02, Mesalazine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-09-15

Date of renewal

Documents

2868_2869_Pentasa 1g_2g_pailg_atp_gran_PL_2025-09-15.docx

2869_Pentasa 2g_pailg_atp_gran_PZ_2025-09-15.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Paketėlyje yra:	1 vnt.
Mesalazinas	2 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118640	104744	1104744	paketėlis	N60		Receptinis	LT/L/25/2869/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-09-15	Registruotas